Cipla's Vice Chairman and Non-Executive Director, Mr. M K Hamied, has resigned from his position due to age and health reasons. His resigna...

"Post transaction, the entire promoter group, including persons acting in concert, continues to hold 31.67% in the company and remains comm...

Samina Hamied, executive vice-chairperson of Cipla, announced her decision to step down from her executive role due to personal and family ...

Drug major Cipla on Thursday said Samina Hamied has decided to step down from the position of Executive Vice Chairperson of the company, wh...

Prospective buyers of a stake in Indian pharmaceutical company Cipla Ltd. are hesitant due to the high valuation demanded by the founding f...

Non-binding bid likely next week for 33.4% stake, will trigger open offer for 26% more. At current mkt value deal size could be over $6 bn ...

Dr Y K Hamied, Chairman and MK Hamied, Vice Chairman who are Non-Executive Directors and promoters, have sold 2,01,69,756 shares, represent...

Launching the Annual Summit 2020 of industry body OPPI, Gowda also said that the contribution of Indian pharmaceutical sector has been rein...

The deal comes with a potential revision linked to FY17 performance along with customary adjustment (within the price band of 250 mn Rand a...

Lankau is currently a principal of Lankau Consulting LLC. He serves on the Board of Directors of ANI Pharmaceuticals Inc and Phosphagenics ...

Cipla is in the midst of preparing itself for an exciting future and her background of both business and advisory will be very useful to th...

Vaziralli, daughter of MK Hamied -- the company's non-executive VC - has been a part of the core leadership team since joining the Mumbai-b...

The transfer of shares is being done by way of gift, the filing said, adding that the purpose was "Re-alignment of family shareholding".

Cipla patriarch YK Hamied plans to increase his holding to over 20 per cent by acquiring over 5 per cent additional stake in the homegrown ...

India's third largest drug maker Cipla has appointed Naina Lal Kidwai on its board as an independent director.

Drug firm Cipla today approved the retirement of its Executive Vice-Chairman, M K Hamied with effect from March 31, 2014.

DNDi is a not-for-profit research and development organisation working to deliver new treatments for neglected diseases.